BioCentury
ARTICLE | Clinical News

Imvamune: Ph III started

December 6, 2016 8:01 PM UTC

Bavarian Nordic said the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) completed enrollment of 440 subjects in a Phase III trial comparing Imvamune vs. ACAM2000, an FDA-approv...

BCIQ Company Profiles

Bavarian Nordic A/S